Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kamlesh Kumar Gupta is active.

Publication


Featured researches published by Kamlesh Kumar Gupta.


Indian Journal of Nephrology | 2016

Neutrophil gelatinase-associated lipocalin as a biomarker of disease progression in patients with chronic kidney disease

Munna Lal Patel; Rekha Sachan; Amita Verma; R Kamal; Kamlesh Kumar Gupta

Chronic kidney disease (CKD) is associated with early mortality, decreased quality of life and increased health care expenditures. The aim of this study was to determine whether or not urinary NGAL (uNGAL) level is associated with renal damage and kidney disease progression in patients with CKD and to evaluate the predictive value of uNGAL in progression of CKD. Totally, 91 cases of CKD stage II, III, IV, and 50 age-matched healthy controls were enrolled. The follow-up end-point was 18 months; end-point of the study was progression to an estimated glomerular filtration rate (eGFR) of <15 ml/min and/or CKD stage V. Forty-five cases (49.4%) were progressors and 46 were nonprogressors. uNGAL levels were significantly higher in CKD subjects as compared to healthy controls (log 1.09 ± 0.22 μg/ml in controls versus log 1.22 ± 2.08 μg/ml in stage II, log 3.34 ± 2.74 μg/ml in stage III and log 3.70 ± 0.18 μg/ml in stage IV). Univariate Cox proportional hazards model showed that only eGFR (hazard ratio [HR]: 0.95; 95% confidence interval [CI]: 0.93–0.96; P < 0.001) and uNGAL (HR: 1.11; 95% CI: 1.01–1.20; P < 0.001) were significantly associated with end-point of CKD stage V, but multiple Cox proportional regression model showed significant association of uNGAL (HR: 1.11; 95% CI: 1.01–1.20; P < 0.001) and eGFR (HR: 0.962, 95% CI: 0.95–0.98; P < 0.001) with end-point of CKD stage V. This suggests that uNGAL would not be a simple surrogate index of baseline eGFR, but a marker of CKD progression beyond the information provided by eGFR estimation.


Indian Journal of Nephrology | 2015

Reduction of microalbuminuria in type-2 diabetes mellitus with angiotensin-converting enzyme inhibitor alone and with cilnidipine

Varun Kumar Singh; Arvind Mishra; Kamlesh Kumar Gupta; R Misra; Ml Patel; Shilpa

The aim of our study was to find out the antiproteinuric effect of enalapril angiotensin-converting enzyme (ACE inhibitor) alone or in combination with cilnidipine in patients with type-2 diabetes mellitus. The study was conducted on 71 patients with type-2 diabetes mellitus patients with hypertension and microalbuminuria. They were divided into two groups randomly as follows: Group I (enalaprilalone, n = 36) and Group II (enalapril with cilnidipine, n = 35). In both the groups, baseline 24 h urinary albumin was estimated and was repeated every 3 months upto 1-year. After 1-year follow-up, reduction in microalbuminuria was found to be greater in Group II. In Group I microalbuminuria came down by 25.68 ± 21.40 while in Group II it reduced by 54.88 ± 13.84 (P < 0.001). We conclude that in diabetic population, cilnidipine has an additive effect in microalbuminuria reduction over and above the well-proven effect of ACE inhibitors.


Lung India | 2016

Prevalence of psychiatric comorbidities in chronic obstructive pulmonary disease patients

Shyam Chand Chaudhary; Satyan Nanda; Adarsh Tripathi; Kamal Kumar Sawlani; Kamlesh Kumar Gupta; D Himanshu; Ajay Kumar Verma

Introduction: Psychiatric disorders, especially anxiety and depression have been reported to have an increased prevalence in chronic obstructive pulmonary disease (COPD) patients, but there is a paucity of data from India. Aims and Objectives: Aim of our study is to study the frequency of psychiatric comorbidities in COPD patients and their correlation with severity of COPD, as per global initiative for obstructive lung disease guidelines. Materials and Methods: This study was conducted in outpatient department of a tertiary care hospital (King Georges Medical University). A total of 74 COPD patients were included in this study and compared with 74 controls. The diagnosis and severity of COPD were assessed by spirometry. Psychiatric comorbidities were assessed using the Mini International Neuropsychiatric Interview questionnaire. Results: The frequency of psychiatric comorbidities was significantly higher (P < 0.05) in COPD patients (28.4%) as compared to controls (2.7%). As regards to severity, the frequency was significantly increased in severe and very severe COPD. The frequency of psychiatric comorbidities in COPD patients increased significantly with the increase in duration of symptoms being present in 67% of patients with duration of symptoms more than 10 years and only 23% of patients with duration of symptoms ≤5 years. Conclusion: The frequency of psychiatric comorbidities is increased in COPD patients as compared to controls. We recommend that all patients with COPD should be screened for psychiatric comorbidity, if any.


Journal of research in pharmacy practice | 2016

Drug reaction with eosinophilia and systemic symptoms syndrome associated with Nitrofurantoin

Jitendra Singh; Anju Dinkar; Virendra Atam; Kamlesh Kumar Gupta; Krishna Kumar Sahani

Drug reaction with eosinophilia and systemic symptom (DRESS) is a severe adverse drug-induced reaction with a prolonged latency period which is characterized by a variety of clinical manifestations, usually fever, rash, lymphadenopathy, eosinophilia, and a wide range of mild-to-severe systemic presentations. Drugs are an important cause of DRESS in most of the cases. It is challenging to diagnose DRESS because of the diversity of cutaneous eruption and visceral organs involvement. We hereby report a 34-year-old female who developed DRESS syndrome following ingestion of nitrofurantoin for the treatment of urinary tract infection. She was managed conservatively and recovered after few weeks. Our aim of this study is to raise awareness to suspect DRESS syndrome in patients who present with unusual clinical features with skin involvement after initiating any drug.


Journal of family medicine and primary care | 2018

Prevalence of pulmonary artery hypertension in patients of chronic obstructive pulmonary disease and its correlation with stages of chronic obstructive pulmonary disease, exercising capacity, and quality of life

Kamlesh Kumar Gupta; Bidyut Roy; Shyam Chand Chaudhary; Arvind Mishra; Munna Lal Patel; Jitendra Singh; Vivek Kumar

Background: Pulmonary arterial hypertension (PAH) is a complication of chronic obstructive pulmonary disease (COPD) in advance stages, and its presence indicates poor prognosis. Aims and Objective: The present study was design to know the prevalence of PAH in patients with COPD and its correlation with stages of COPD, exercising capacity, and quality of life. Materials and Methods: It is a cross-sectional prevalence study over a period of 1 year from August 2015 to July 2016. The study included 109 COPD patients, diagnosed by spirometry, and severity was determined according Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification criteria. Screening two-dimensional echocardiography was done to determine pulmonary arterial hypertension and exercising capacity assessed by 6 min walk test (6MWT) while the quality of life was assessed by St George respiratory Questionnaire for COPD (SGRQ-C) Questionnaires. Results: Out of 109 patients, PAH was present in 68 (62.4%) cases consisting of mild grade 41 (37.6%), moderate grade 11 (10.1%), and severe grade 16 (14.7%). In GOLD A stage, there were 20 cases of mild PAH and Stage B included 18 cases of mild and 3 cases of moderate PAH. Stage C had 3 cases of mild and 8 cases of moderate PAH while Stage D had 16 cases of severe PAH. In 6MWT, patients with severe grade PAH fail to perform the test while patients with mild to moderate PAH walked short distance. In SGRQ-C Questionnaires symptom, activity, impact, and total score were high with the severity of PAH. Conclusion: The prevalence of PAH in COPD was significant. Therefore, every COPD patient should be evaluated for PAH.


International Journal of Research in Medical Sciences | 2018

Serological and molecular approaches for leptospirosis at a tertiary care centre in northern India

Saurabh Chaurasia; Raj Kumar Kalyan; Prashant K Gupta; Kamlesh Kumar Gupta; Chandra Kanta; Akanksha Gupta

Background: Aims and objectives of the study was to determine prevalence rate of leptospirosis and recognition of common epidemiological situation and clinical manifestations of leptospirosis in patients with pyrexia of unknown origin at a tertiary care centre. Methods: This was a hospital based prospective observational study. The duration of study was from August 2015 to July 2016. Patients with clinical symptoms of pyrexia of unknown origin attending Gandhi Memorial and Associated Hospital, King George’s Medical University Lucknow during the study period were enrolled in this study. We performed the IgM ELISA and PCR for the leptospirosis at our centre and for the Micro Agglutination Test (MAT), we sent the serum samples to regional medical research centre Department of Health Research Ministry of Health and Family Welfare, Govt. of India Port Blair. Results: A Total of 104 symptomatic patients were recruited. Of total, IgM ELISA for leptospirosis were positive in 25 patients, PCR in 20 patients and MAT shows significant titres in 3 samples. The ROC curve analysis revealed significant diagnostic accuracy of IgM ELISA with 100.00% sensitivity and 78.22% specificity however showed less positive predictive value (12.0%) but high negative predictive value (100.0%). Most common presentation were fever, jaundice and rashes (40.4%) followed by fever and jaundice (29.8%). Conclusions: Leptospirosis IgM ELISA and PCR showed good detection accuracy. Age, sex, occupation is not significantly associated to the leptospirosis.


Indian Journal of Nephrology | 2016

Acquired Bartter syndrome following gentamicin therapy

Jitendra Singh; Munna Lal Patel; Kamlesh Kumar Gupta; S Pandey; A Dinkar

Aminoglycoside nephrotoxicity may manifest as nonoliguric renal failure or tubular dysfunction, such as Fanconi-like syndrome, Bartter-like syndrome (BS), or distal renal tubular acidosis. We report a case who developed severe renal tubular dysfunction on the the 7th day of gentamicin therapy, resulting in metabolic alkalosis, refractory hypokalemia, hypocalcemia, hypomagnesemia, and polyuria. The patient was diagnosed as a case of transient BS associated with gentamicin exposure. The patient recovered with conservative management.


Archive | 2014

Dengue Encephalitis with Acute Intracerebral Infarction and Facial Palsy; A Rare Presentation

Jitendra Singh; Anju Dinkar; Kamlesh Kumar Gupta; Anurag Kumar Singh; Saurabh Kumar; Dandu Himanshu


Archive | 2015

Intracranial Hemorrhage in Dengue Fever: A Case Series

Jitendra Singh; Anju Dinkar; Virendra Atam; Ravi Misra; Saurabh Kumar; Kamlesh Kumar Gupta


Archive | 2014

Enteric Fever Complicated to Acute Pancreatitis; a Case Report

Jitendra Singh; Anju Dinkar; Kamlesh Kumar Gupta

Collaboration


Dive into the Kamlesh Kumar Gupta's collaboration.

Top Co-Authors

Avatar

Jitendra Singh

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Anju Dinkar

King George's Medical University

View shared research outputs
Top Co-Authors

Avatar

Arvind Mishra

King George's Medical University

View shared research outputs
Top Co-Authors

Avatar

Virendra Atam

King George's Medical University

View shared research outputs
Top Co-Authors

Avatar

Shyam Chand Chaudhary

King George's Medical University

View shared research outputs
Top Co-Authors

Avatar

D Himanshu

King George's Medical University

View shared research outputs
Top Co-Authors

Avatar

Kamal Kumar Sawlani

King George's Medical University

View shared research outputs
Top Co-Authors

Avatar

Munna Lal Patel

King George's Medical University

View shared research outputs
Top Co-Authors

Avatar

Rohit Anand

King George's Medical University

View shared research outputs
Top Co-Authors

Avatar

Vivek Kumar

King George's Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge